GPCR-mediated inositol phosphate-linked Ca2+ release pathway (Gq-PLC-IP3 pathway)

The GPCR-mediated inositol phosphate-linked Ca2+ release pathway is a fundamental signaling mechanism that regulates the contraction of smooth muscle cells in the vascular, respiratory, and gastrointestinal systems (Source: StatPearls, Physiology, Smooth Muscle Contraction). The process begins when an agonist binds to a Gq-protein-coupled receptor, activating Phospholipase C-beta, which hydrolyzes phosphatidylinositol 4,5-bisphosphate into diacylglycerol and inositol 1,4,5-trisphosphate (IP3) (Source: NIH, Molecular Biology of the Cell). IP3 then acts as a second messenger, diffusing through the cytosol to bind to IP3 receptors on the sarcoplasmic reticulum, triggering the rapid release of sequestered calcium ions (Source: UniProt, ITPR1). This elevation in cytosolic calcium activates calmodulin and myosin light chain kinase, ultimately leading to muscle contraction. Dysregulation of this pathway is central to the pathogenesis of conditions like hypertension and asthma, where excessive smooth muscle tone leads to clinical symptoms (Source: PubMed, PMC3136057). Pharmacological interventions often target the upstream receptors in this pathway, such as muscarinic or angiotensin receptors, to modulate calcium release and alleviate pathological constriction.

Other names

Gq-protein-coupled receptor signalingPhosphoinositide signaling pathwayIP3-mediated calcium signalingPLC-IP3-Ca2+ axisGq-PLC-IP3 signaling cascade

Antagonism of Gq-coupled receptors to inhibit the Phospholipase C-mediated generation of Inositol 1,4,5-trisphosphate, thereby preventing the release of calcium from the sarcoplasmic reticulum and subsequent smooth muscle contraction.